irasia.com - Investor Relations Asia Pacific
HOME

CSPC Pharmaceutical Group Limited
(Incorporated in Hong Kong with limited liability)

Announcements & Notices       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2016-December-14
  • VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND CO-DEVELOPMENT AGREEMENT (in PDF)
  • 2016-December-12
  • VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AGREEMENT (in PDF)
  • 2016-November-23
  • UNAUDITED RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2016 (in PDF)
  • 2016-November-21
  • INSIDE INFORMATION AND RESUMPTION OF TRADING (in PDF)
  • 2016-November-21
  • TRADING HALT (in PDF)
  • 2016-November-11
  • DATE OF BOARD MEETING (in PDF)
  • 2016-August-26
  • COMPLETION OF EXERCISE OF THE EXISTING SHARE OPTIONS (in PDF)
  • 2016-August-23
  • 2016 INTERIM RESULTS ANNOUNCEMENT (in PDF)
  • 2016-August-11
  • DATE OF BOARD MEETING (in PDF)
  • 2016-June-27
  • CONTINUING CONNECTED TRANSACTIONS - LEASE AGREEMENTS (in PDF)
  • 2016-June-13
  • (1) COMPLETION OF THE ACQUISITION OF 93.18% EQUITY INTEREST IN CSPC SHENGXUE GLUCOSE CO., LTD. AND (2) CONTINUING CONNECTED TRANSACTIONS (in PDF)
  • 2016-June-6
  • LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
  • 2016-June-6
  • APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES (in PDF)
  • 2016-May-30
  • POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 30 MAY 2016 (in PDF)
  • 2016-May-18
  • UNAUDITED RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2016 (in PDF)
  • 2016-May-6
  • DATE OF BOARD MEETING (in PDF)
  • 2016-April-25
  • VOLUNTARY ANNOUNCEMENT - PRODUCT TECHNOLOGY LICENSING AGREEMENT (in PDF)
  • 2016-April-21
  • NOTICE OF ANNUAL GENERAL MEETING (in PDF)
  • 2016-April-20
  • VOLUNTARY ANNOUNCEMENT - THE GROUP'S CHEMICAL DRUG "BUTYLPHTHALIDE SOFT CAPSULES" WAS GRANTED CLINICAL TRIAL APPROVAL IN RELATION TO A NEW INDICATION FOR VASCULAR DEMENTIA (in PDF)
  • 2016-April-20
  • VOLUNTARY ANNOUNCEMENT-CLARIFICATION OF ARTICLES (in PDF)
  • 2016-April-14
  • CONNECTED TRANSACTION - ACQUISITION OF 93.18% EQUITY INTEREST IN CSPC SHENGXUE GLUCOSE CO., LTD. (in PDF)
  • 2016-April-8
  • NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES (in PDF)
  • 2016-March-21
  • ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015 (in PDF)
  • 2016-March-9
  • DATE OF BOARD MEETING (in PDF)
  • 2016-February-25
  • VOLUNTARY ANNOUNCEMENT - THE GROUP'S ONCOLOGY DRUG "SKLB1028 CAPSULES" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
  • 2016-February-5
  • VOLUNTARY ANNOUNCEMENT - APPROVAL GRANTED FOR THE COMMENCEMENT OF CLINICAL TRIALS FOR THE GROUP'S PRODUCTS (in PDF)
  • 2016-January-11
  • LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
  • 2016-January-8
  • RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES (in PDF)
  • 2024
  • 2024 Announcements & Notices
  • 2023
  • 2023 Announcements & Notices
  • 2022
  • 2022 Announcements & Notices
  • 2021
  • 2021 Announcements & Notices
  • 2020
  • 2020 Announcements & Notices
  • 2019
  • 2019 Announcements & Notices
  • 2018
  • 2018 Announcements & Notices
  • 2017
  • 2017 Announcements & Notices
  • 2015
  • 2015 Announcements & Notices
  • 2014
  • 2014 Announcements & Notices
  • 2013
  • 2013 Announcements & Notices
  • 2012
  • 2012 Announcements & Notices
  • 2011
  • 2011 Announcements & Notices
  • 2010
  • 2010 Announcements & Notices
  • 2009
  • 2009 Announcements & Notices
  • 2008
  • 2008 Announcements & Notices
  • 2007
  • 2007 Announcements & Notices
  • 2006
  • 2006 Announcements & Notices


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2024 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.
    Cookie Policy

    This website uses cookies. Please refer to our Cookie Notice and Privacy Notice for further information. By continuing to use this website, you agree to our use of cookies.

    Close